HIGH-RISK LUNG NODULES

Clinical trials for HIGH-RISK LUNG NODULES explained in plain language.

Never miss a new study

Get alerted when new HIGH-RISK LUNG NODULES trials appear

Sign up with your email to follow new studies for HIGH-RISK LUNG NODULES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a drug stop lung spots from becoming cancer? new trial for smokers.

Prevention Recruiting now

This study tests a drug called nadunolimab to see if it can shrink high-risk lung nodules in current or former heavy smokers. About 59 people will receive the drug and be followed for up to 5 years. The goal is to prevent these nodules from turning into lung cancer.

Matched conditions: HIGH-RISK LUNG NODULES

Phase: PHASE2 • Sponsor: Robert Samstein • Aim: Prevention

Last updated May 07, 2026 18:42 UTC

HIGH-RISK LUNG NODULES

Get alerted when new HIGH-RISK LUNG NODULES trials appear

Can a drug stop lung spots from becoming cancer? new trial for smokers.